Fundraising FoxPTX Capital — Full Portfolio
3 tracked investments · listed companies and verified rows first
Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins.
BiotechDeep TechHealthtechBaltimore, US
Benjamin Larman(Executive Officer, Director)inJoy M Nassif(Executive Officer, Director)in
BoardHerman Scholtz(Director)inCaroline Popper(Director)in
Board seatMatthew Hellauer· per SEC Form D · $7M raise · filed Aug 2025
Co-investorsIllumina VenturesTCP Venture Capital
Pair Team develops an AI-enabled care coordination platform that connects people with healthcare providers and programs to deliver proactive, personalized care.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Neil Batlivala(Founder)inCassie Choi(Founder)inCassandra Choi(Executive Officer, Director)inAndres Calabrese(Engineer)Lucas Cook(Software Engineer)Lori Sparks(Recruiting)
Co-investorsAugment VenturesCraft VenturesCREATE HEALTH VENTURESGaingelsHead & Heart CapitalHeadwater Ventures+18 more
__Twitter.png)
Scene provides digital medication adherence programs combining video check-ins and human engagement by nurses and pharmacists to improve patient adherence and health outcomes across health systems and care organizations.
Digital HealthHealthtechMedical DevicesSaaSBaltimore, US
Sebastian Seiguer(Entrepreneur & Founder)inMorad ElmiSebastian Seiguer, JD, MBA(Founder)inMorad E.(Founder)in
Co-investorsGaingelsKapor CapitalTCP Venture CapitalABS Capital PartnersBold Capital PartnersGreycroft+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.